These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941 [TBL] [Abstract][Full Text] [Related]
4. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC; Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739 [TBL] [Abstract][Full Text] [Related]
5. Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy". Sherertz EF; Jegasothy BV; Lazarus GS J Am Acad Dermatol; 1985 Jan; 12(1 Pt 2):178-81. PubMed ID: 3973116 [TBL] [Abstract][Full Text] [Related]
7. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica. East-Innis AD; Thompson DS West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894 [TBL] [Abstract][Full Text] [Related]
8. Delayed hypersensitivity in drug-induced toxic epidermal necrolysis (TEN). Wolf R; Livni E; Joshua H Arch Dermatol; 1984 Dec; 120(12):1555. PubMed ID: 6508326 [No Abstract] [Full Text] [Related]
9. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523 [TBL] [Abstract][Full Text] [Related]
10. Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that 'toxic' epidermal necrolysis can be 'non-toxic'. Dumas M; Hua C; Hotz C; Velter C; Duong TA; Maraffi T; Ortonne N; Hüe S; Fardet L; de Prost N; Wolkenstein P; Ingen-Housz-Oro S; Chosidow O J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):e360-e361. PubMed ID: 29524279 [No Abstract] [Full Text] [Related]
15. T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction. Ko TM; Chen YT Expert Rev Clin Immunol; 2012 Jul; 8(5):467-77. PubMed ID: 22882221 [TBL] [Abstract][Full Text] [Related]
16. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164 [TBL] [Abstract][Full Text] [Related]
17. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)]. Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218 [TBL] [Abstract][Full Text] [Related]
18. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions. Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341 [TBL] [Abstract][Full Text] [Related]
19. Aetiology in sixteen cases of toxic epidermal necrolysis and Stevens-Johnson syndrome admitted within eight months in a teaching hospital. Yeung CK; Ma SY; Hon C; Peiris M; Chan HH Acta Derm Venereol; 2003; 83(3):179-82. PubMed ID: 12816151 [TBL] [Abstract][Full Text] [Related]
20. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis]. van der Meer JB Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761 [No Abstract] [Full Text] [Related] [Next] [New Search]